Provided by Tiger Trade Technology Pte. Ltd.

Biofrontera Inc

0.7787
-0.0113-1.43%
Post-market: 0.7700-0.0087-1.12%19:47 EST
Volume:114.77K
Turnover:90.04K
Market Cap:9.07M
PE:-0.42
High:0.7904
Open:0.7821
Low:0.7656
Close:0.7900
52wk High:1.19
52wk Low:0.5360
Shares:11.65M
Float Shares:9.11M
Volume Ratio:0.04
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8444
EPS(LYR):-3.2193
ROE:-1191.73%
ROA:-64.91%
PB:-3.51
PE(LYR):-0.24

Loading ...

Company Profile

Company Name:
Biofrontera Inc
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
93
Office Location:
120 Presidential Way,Suite 330,Woburn,Massachusetts,United States
Zip Code:
01801
Fax:
- -
Introduction:
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Directors

Name
Position
Hermann Luebbert
Executive Chairman of the Board and Chief Executive Officer
Beth J. Hoffman
Independent Director
John J. Borer
Independent Director
Kevin D. Weber
Independent Director
Heikki Lanckriet
Director

Shareholders

Name
Position
Hermann Luebbert
Executive Chairman of the Board and Chief Executive Officer
Eugene Fredrick Leffler, III
Chief Financial Officer and Principal Accounting Officer
George Jones
Chief Commercial Officer